UNSPSC 51152021: Clodanolene

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 96L9G9BL3X. European Medicines Agency schedules Clodanolene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06689MIG. Clodanolene generally arises in the molecular formula C14H9CL2N3O3.

UNSPSC 51152021 Clodanolene is a Commodity code that state and local governments use to procure naloxone and drug deactivation systems for public health and emergency response purposes. The code encompasses pharmaceutical products and related safety equipment deployed by health departments, emergency services, and community health agencies to address opioid overdose and controlled-substance disposal. Issuing bodies under this code include county health departments and state health agencies; the recent activity shows Seminole County, Florida and the Texas Health and Human Services Commission actively sourcing these products and related supply-chain capabilities. Procurement structures vary from fixed-price competitive bids for direct product purchase to exploratory requests for information gathering vendor capacity for pharmacy-benefit and direct-to-manufacturer contracting models.

Recent opportunities span Florida and Texas. Seminole County posted an IFB (Solicitation Number IFB60459723LAS, response due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the contract carries a two-year initial term with one-year renewal option and includes FEMA funding contingency. The Texas Health and Human Services Commission issued an RFI (HHS0017013, response deadline April 3, 2026) to explore vendor capabilities for implementing direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager and group purchasing organization channels, signaling state-level interest in alternative supply and contracting models for pharmaceutical procurement. Both solicitations require E-Verify compliance and drug-free workplace certification from vendors.